ReP USP - Resultado da busca

Artigo de periodico
Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial (2019)
Vieira, Carolina Sales ; Nadai, Mariane Nunes de ; Carmo, Lilian Sheila de Melo Pereira do; Braga, Giordana Campos ; Infante, Bruna Fregonesi; Stifani, Bianca M.; Ferriani, Rui Alberto ; Quintana, Silvana Maria
Source: Contraception. Unidade: FMRP
Subjects: CONTROLE DE NATALIDADE, FÁRMACOS (SISTEMA REPRODUTOR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial. Contraception, v. 100, n. 4, p. 258-263, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2019.05.007. Acesso em: 10 nov. 2024.
APA
Vieira, C. S., Nadai, M. N. de, Carmo, L. S. de M. P. do, Braga, G. C., Infante, B. F., Stifani, B. M., et al. (2019). Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial. Contraception, 100( 4), 258-263. doi:10.1016/j.contraception.2019.05.007
NLM
Vieira CS, Nadai MN de, Carmo LS de MP do, Braga GC, Infante BF, Stifani BM, Ferriani RA, Quintana SM. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial [Internet]. Contraception. 2019 ; 100( 4): 258-263.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2019.05.007
Vancouver
Vieira CS, Nadai MN de, Carmo LS de MP do, Braga GC, Infante BF, Stifani BM, Ferriani RA, Quintana SM. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial [Internet]. Contraception. 2019 ; 100( 4): 258-263.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2019.05.007
Artigo de periodico
Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact (2015)
Braga, Giordana Campos; Ferriolli, Eduardo; Quintana, Silvana Maria; Ferriani, Rui Alberto; Pfrimer, Karina; Vieira, Carolina Sales
Source: Contraception. Unidade: FMRP
Subjects: ALEITAMENTO MATERNO, HORMÔNIOS, PRÓTESES E IMPLANTES, PUERPÉRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Giordana Campos et al. Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact. Contraception, v. 92, p. 536-542, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2015.07.009. Acesso em: 10 nov. 2024.
APA
Braga, G. C., Ferriolli, E., Quintana, S. M., Ferriani, R. A., Pfrimer, K., & Vieira, C. S. (2015). Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact. Contraception, 92, 536-542. doi:10.1016/j.contraception.2015.07.009
NLM
Braga GC, Ferriolli E, Quintana SM, Ferriani RA, Pfrimer K, Vieira CS. Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact [Internet]. Contraception. 2015 ; 92 536-542.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2015.07.009
Vancouver
Braga GC, Ferriolli E, Quintana SM, Ferriani RA, Pfrimer K, Vieira CS. Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact [Internet]. Contraception. 2015 ; 92 536-542.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2015.07.009
Artigo de periodico
Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis (2014)
Braga, Giordana Campos; Brito, Milena Bastos; Ferriani, Rui Alberto; Oliveira, Luciana Correa; Garcia, Andrea Aparecida; Pintão, Maria Carolina; Vieira, Carolina Sales
Source: Contraception. Unidade: FMRP
Subjects: TROMBOSE, ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Giordana Campos et al. Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis. Contraception, v. 89, n. 1, p. 48-53, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2013.06.012. Acesso em: 10 nov. 2024.
APA
Braga, G. C., Brito, M. B., Ferriani, R. A., Oliveira, L. C., Garcia, A. A., Pintão, M. C., & Vieira, C. S. (2014). Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis. Contraception, 89( 1), 48-53. doi:10.1016/j.contraception.2013.06.012
NLM
Braga GC, Brito MB, Ferriani RA, Oliveira LC, Garcia AA, Pintão MC, Vieira CS. Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis [Internet]. Contraception. 2014 ; 89( 1): 48-53.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2013.06.012
Vancouver
Braga GC, Brito MB, Ferriani RA, Oliveira LC, Garcia AA, Pintão MC, Vieira CS. Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis [Internet]. Contraception. 2014 ; 89( 1): 48-53.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2013.06.012
Artigo de periodico
Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium (2013)
Franceschini, Silvio Antonio; Vieira, Carolina Sales; Martins, Wellington de Paula; França, Janaína Boldrini; Ferriani, Rui Alberto
Source: Contraception. Unidade: FMRP
Subjects: DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, ENDOTÉLIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCESCHINI, Silvio Antonio et al. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium. Contraception, v. 87, n. 6, p. 766-772, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2012.09.023. Acesso em: 10 nov. 2024.
APA
Franceschini, S. A., Vieira, C. S., Martins, W. de P., França, J. B., & Ferriani, R. A. (2013). Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium. Contraception, 87( 6), 766-772. doi:10.1016/j.contraception.2012.09.023
NLM
Franceschini SA, Vieira CS, Martins W de P, França JB, Ferriani RA. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium [Internet]. Contraception. 2013 ; 87( 6): 766-772.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2012.09.023
Vancouver
Franceschini SA, Vieira CS, Martins W de P, França JB, Ferriani RA. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium [Internet]. Contraception. 2013 ; 87( 6): 766-772.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2012.09.023
Artigo de periodico
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. (2012)
Vieira, Carolina Sales; Martins, Wellington de P.; Fernandes, Janaína Boldrini França; Soares, Gustavo Mafaldo; Reis, Rosana Maria dos; Sá, Marcos Felipe Silva de; Ferriani, Rui Alberto
Source: Contraception. Unidade: FMRP
Subjects: SÍNDROME DO OVÁRIO POLICÍSTICO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, v. 86, n. 3, p. 268-275, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2011.12.11. Acesso em: 10 nov. 2024.
APA
Vieira, C. S., Martins, W. de P., Fernandes, J. B. F., Soares, G. M., Reis, R. M. dos, Sá, M. F. S. de, & Ferriani, R. A. (2012). The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, 86( 3), 268-275. doi:10.1016/j.contraception.2011.12.11
NLM
Vieira CS, Martins W de P, Fernandes JBF, Soares GM, Reis RM dos, Sá MFS de, Ferriani RA. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. [Internet]. Contraception. 2012 ; 86( 3): 268-275.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2011.12.11
Vancouver
Vieira CS, Martins W de P, Fernandes JBF, Soares GM, Reis RM dos, Sá MFS de, Ferriani RA. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. [Internet]. Contraception. 2012 ; 86( 3): 268-275.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2011.12.11
Artigo de periodico
Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue (2010)
Ferreira, Rodrigo Alves; Vieira, Carolina Sales; Rosa e Silva, Júlio César; Rosa e Silva, Ana Carolina Japur de Sá; Nogueira, Antonio Alberto; Ferriani, Rui Alberto
Source: Contraception. Unidade: FMRP
Subjects: ENDOMETRIOSE, DOENÇAS CARDIOVASCULARES, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rodrigo Alves et al. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Contraception, v. 81, n. 2, p. 117-122, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2009.08.003. Acesso em: 10 nov. 2024.
APA
Ferreira, R. A., Vieira, C. S., Rosa e Silva, J. C., Rosa e Silva, A. C. J. de S., Nogueira, A. A., & Ferriani, R. A. (2010). Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Contraception, 81( 2), 117-122. doi:10.1016/j.contraception.2009.08.003
NLM
Ferreira RA, Vieira CS, Rosa e Silva JC, Rosa e Silva ACJ de S, Nogueira AA, Ferriani RA. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue [Internet]. Contraception. 2010 ; 81( 2): 117-122.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2009.08.003
Vancouver
Ferreira RA, Vieira CS, Rosa e Silva JC, Rosa e Silva ACJ de S, Nogueira AA, Ferriani RA. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue [Internet]. Contraception. 2010 ; 81( 2): 117-122.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2009.08.003
Artigo de periodico
Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study (2009)
Brito, Milena Bastos; Ferriani, Rui Alberto; Quintana, Silvana Maria; Yazlle, Marta Edna Holanda Diogenes; Sá, Marcos Felipe Silva de; Vieira, Carolina Sales
Source: Contraception. Unidade: FMRP
Subjects: ALEITAMENTO MATERNO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS (EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITO, Milena Bastos et al. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception, v. 80, n. 6, p. 519-526, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2009.05.124. Acesso em: 10 nov. 2024.
APA
Brito, M. B., Ferriani, R. A., Quintana, S. M., Yazlle, M. E. H. D., Sá, M. F. S. de, & Vieira, C. S. (2009). Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception, 80( 6), 519-526. doi:10.1016/j.contraception.2009.05.124
NLM
Brito MB, Ferriani RA, Quintana SM, Yazlle MEHD, Sá MFS de, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study [Internet]. Contraception. 2009 ; 80( 6): 519-526.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2009.05.124
Vancouver
Brito MB, Ferriani RA, Quintana SM, Yazlle MEHD, Sá MFS de, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study [Internet]. Contraception. 2009 ; 80( 6): 519-526.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2009.05.124
Artigo de periodico
Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women (2009)
Lizarelli, Patrícia Margareth; Martins, Wellington de Paula; Soares, Gustavo Mafaldo; Macedo, Carolina Sales Vieira; Franceschini, Silvio Antonio; Ferriani, Rui Alberto; Patta, Maristela Carbol
Source: Contraception. Unidade: FMRP
Subjects: DISPOSITIVOS ANTICONCEPCIONAIS, ENDOTÉLIO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIZARELLI, Patrícia Margareth et al. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Contraception, v. 79, n. 1, p. 35-40, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2008.07.024. Acesso em: 10 nov. 2024.
APA
Lizarelli, P. M., Martins, W. de P., Soares, G. M., Macedo, C. S. V., Franceschini, S. A., Ferriani, R. A., & Patta, M. C. (2009). Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Contraception, 79( 1), 35-40. doi:10.1016/j.contraception.2008.07.024
NLM
Lizarelli PM, Martins W de P, Soares GM, Macedo CSV, Franceschini SA, Ferriani RA, Patta MC. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women [Internet]. Contraception. 2009 ; 79( 1): 35-40.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2008.07.024
Vancouver
Lizarelli PM, Martins W de P, Soares GM, Macedo CSV, Franceschini SA, Ferriani RA, Patta MC. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women [Internet]. Contraception. 2009 ; 79( 1): 35-40.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.contraception.2008.07.024

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Indexado em